VULINACIMAB
UNII SA09JNQ24D

Substance Identification & Data

This profile provides standardized clinical and technical data for Vulinacimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SA09JNQ24D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2250342-36-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SA09JNQ24D

CAS Registry Number

2250342-36-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VULINACIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156172

National Cancer Institute reference terminology for clinical and research data.

INN ID

11308

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vulinacimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VULINACIMAB

Common Names & Synonyms

ANTI-VEGFR2 MONOCLONAL ANTIBODY HLX06

MAB HUMAN (IGG1) ANTI P35968 (VGFR2_HUMAN) (HLX06)

VULINACIMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2)(HUMAN MONOCLONAL HLX06 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HLX06 .KAPPA.-CHAIN), DIMER

SYS